API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
20
PharmaCompass offers a list of Thymalfasin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Thymalfasin manufacturer or Thymalfasin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Thymalfasin manufacturer or Thymalfasin supplier.
PharmaCompass also assists you with knowing the Thymalfasin API Price utilized in the formulation of products. Thymalfasin API Price is not always fixed or binding as the Thymalfasin Price is obtained through a variety of data sources. The Thymalfasin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Thymalfasin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Thymalfasin, including repackagers and relabelers. The FDA regulates Thymalfasin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Thymalfasin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Thymalfasin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Thymalfasin supplier is an individual or a company that provides Thymalfasin active pharmaceutical ingredient (API) or Thymalfasin finished formulations upon request. The Thymalfasin suppliers may include Thymalfasin API manufacturers, exporters, distributors and traders.
click here to find a list of Thymalfasin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Thymalfasin DMF (Drug Master File) is a document detailing the whole manufacturing process of Thymalfasin active pharmaceutical ingredient (API) in detail. Different forms of Thymalfasin DMFs exist exist since differing nations have different regulations, such as Thymalfasin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Thymalfasin DMF submitted to regulatory agencies in the US is known as a USDMF. Thymalfasin USDMF includes data on Thymalfasin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Thymalfasin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Thymalfasin suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Thymalfasin Drug Master File in Korea (Thymalfasin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Thymalfasin. The MFDS reviews the Thymalfasin KDMF as part of the drug registration process and uses the information provided in the Thymalfasin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Thymalfasin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Thymalfasin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Thymalfasin suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Thymalfasin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Thymalfasin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Thymalfasin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Thymalfasin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Thymalfasin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Thymalfasin suppliers with NDC on PharmaCompass.
Thymalfasin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Thymalfasin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Thymalfasin GMP manufacturer or Thymalfasin GMP API supplier for your needs.
A Thymalfasin CoA (Certificate of Analysis) is a formal document that attests to Thymalfasin's compliance with Thymalfasin specifications and serves as a tool for batch-level quality control.
Thymalfasin CoA mostly includes findings from lab analyses of a specific batch. For each Thymalfasin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Thymalfasin may be tested according to a variety of international standards, such as European Pharmacopoeia (Thymalfasin EP), Thymalfasin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Thymalfasin USP).